Role of RUNX in autoimmune diseases linking rheumatoid arthritis, psoriasis and lupus
Open Access
- 1 January 2004
- journal article
- review article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 6 (4) , 169-73
Abstract
Recent studies investigating the genetic susceptibility of systemic lupus erythematosus, rheumatoid arthritis and psoriasis have revealed a potential role for the RUNX proteins in the development of autoimmune disease. A new pathway of disease pathogenesis opens new avenues of research with thousands of questions that remain to be answered. In this review I attempt to propose how the RUNX proteins might be involved in these diseases and review current knowledge on this very interesting trio of transcription factors that was previously only suspected to be involved in cancer.Keywords
This publication has 50 references indexed in Scilit:
- Association of the PD‐1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitopeArthritis & Rheumatism, 2004
- A RUNX trio with a taste for autoimmunityNature Genetics, 2003
- RUNX transcription factors as key targets of TGF-β superfamily signalingCurrent Opinion in Genetics & Development, 2003
- Cbfβ interacts with Runx2 and has a critical role in bone developmentNature Genetics, 2002
- Differential Requirements for Runx Proteins in CD4 Repression and Epigenetic Silencing during T Lymphocyte DevelopmentCell, 2002
- A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humansNature Genetics, 2002
- In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesisBlood, 2002
- Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritisArthritis & Rheumatism, 2001
- Structural Analyses of DNA Recognition by the AML1/Runx-1 Runt Domain and Its Allosteric Control by CBFβCell, 2001
- Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.Journal of Experimental Medicine, 1982